Cigna Corporation (CI) Net Profit Margin: 2.26%
Is Cigna Corporation’s net profit margin high or low?
Cigna Corporation's net profit margin of 2.26% is 26% below its 5-year average of 3.04%, near the low end of its 5-year range (1.39%–5.27%).
The net profit margin for Cigna Corporation (CI) is 2.26% as of Wednesday, June 10, 2026. It is above its 12-month average by 26.97% (1.78%).
CI Net Profit Margin Chart
CI Average Net Profit Margin Chart
CI Current vs Average Net Profit Margin Chart
CI Net Profit Margin Metrics
NET PROFIT MARGIN
2.26%
NET PROFIT MARGIN AVG TTM
1.78%
NET PROFIT MARGIN AVG 3Y
2.48%
NET PROFIT MARGIN AVG 5Y
3.04%
NET PROFIT MARGIN AVG 10Y
3.87%
NET PROFIT MARGIN AVG 15Y
4.41%
NET PROFIT MARGIN AVG 20Y
4.87%
CURRENT VS TTM AVG
+26.97%
CURRENT VS 3Y AVG
-8.78%
CURRENT VS 5Y AVG
-25.74%
CURRENT VS 10Y AVG
-41.60%
CURRENT VS 15Y AVG
-48.79%
CURRENT VS 20Y AVG
-53.59%
CI Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | — | 2.26% | 1.78% | 2.48% | 3.04% |
| Elevance Health Inc. (ELV) | $87.43B | 2.62% | 3.11% | 3.37% | 3.60% |
| Regeneron Pharmaceuticals, Inc. (REGN) | $62.59B | 29.65% | 31.24% | 32.06% | 36.64% |
| Medtronic plc (MDT) | $103.04B | 13.20% | 13.55% | 12.62% | 13.06% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 35.40% | 13.94% | 25.44% | 29.40% |
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 24.63% | 23.70% | 22.66% | 22.55% |
| Humana Inc. (HUM) | $43.78B | 0.82% | 0.97% | 1.82% | 2.53% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 15.01% | -1.95% | 6.91% | 3.59% |
| Agilent Technologies, Inc. (A) | $37.17B | 19.55% | 19.27% | 18.75% | 17.94% |
| Zoetis Inc. (ZTS) | $34.20B | 27.79% | 27.55% | 27.17% | 26.57% |
Margin Comparison
Operating Margin
3.4%
Net Profit Margin
2.3%
Cigna Corporation Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cigna Corporation Net Profit Margin FAQ
- What is the net profit margin for Cigna Corporation (CI)?
- The net profit margin for CI stock is 2.26%.
- Is Cigna Corporation's net profit margin high or low?
- Cigna Corporation's net profit margin of 2.26% is 26% below its 5-year average of 3.04%, near the low end of its 5-year range (1.39%–5.27%).
- What is the TTM average net profit margin for Cigna Corporation (CI)?
- The TTM average net profit margin for CI stock is 1.78%.
- What is the 3Y average net profit margin for Cigna Corporation (CI)?
- The 3Y average net profit margin for CI stock is 2.48%.
- What is the 5Y average net profit margin for Cigna Corporation (CI)?
- The 5Y average net profit margin for CI stock is 3.04%.
- What is the 10Y average net profit margin for Cigna Corporation (CI)?
- The 10Y average net profit margin for CI stock is 3.87%.
- What is the 15Y average net profit margin for Cigna Corporation (CI)?
- The 15Y average net profit margin for CI stock is 4.41%.
- What is the 20Y average net profit margin for Cigna Corporation (CI)?
- The 20Y average net profit margin for CI stock is 4.87%.
Cigna Corporation Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | 2.17% |
| 2024-12-31 | 1.39% |
| 2023-12-31 | 2.64% |
| 2022-12-31 | 3.71% |
| 2021-12-31 | 3.08% |
| 2020-12-31 | 5.27% |
| 2019-12-31 | 3.32% |
| 2018-12-31 | 5.42% |
| 2017-12-31 | 5.35% |
| 2016-12-31 | 4.69% |
| 2015-12-31 | 5.53% |
| 2014-12-31 | 6.02% |
| 2013-12-31 | 4.56% |
| 2012-12-31 | 5.57% |
| 2011-12-31 | 5.82% |
| 2010-12-31 | 6.07% |
| 2009-12-31 | 7.07% |
| 2008-12-31 | 1.53% |
| 2007-12-31 | 6.33% |
| 2006-12-31 | 6.98% |
| 2005-12-31 | 9.74% |
| 2004-12-31 | 7.91% |
| 2003-12-31 | 3.36% |
| 2002-12-31 | -2.31% |
| 2001-12-31 | 5.05% |
| 2000-12-31 | 4.84% |
| 1999-12-31 | 9.47% |
| 1998-12-31 | 7.32% |
| 1997-12-31 | 9.22% |
| 1996-12-31 | 5.57% |
Related Metrics
About Cigna Corporation
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- David Michael Cordani